{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:36:49Z","timestamp":1791362209915,"version":"4.3.1"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:00:00Z","timestamp":1182211200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.0040206","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T17:17:01Z","timestamp":1181668621000},"page":"e206","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":273,"title":["Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target"],"prefix":"10.1371","volume":"4","author":[{"given":"Angela N","family":"Kuntz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Davioud-Charvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay L","family":"Califf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Dessolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S. J","family":"Arn\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,6,19]]},"reference":[{"key":"pmed-0040206-b001","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)66457-4","article-title":"Reassessment of the cost of chronic helmintic infection: A meta-analysis of disability-related outcomes in endemic schistosomiasis.","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"pmed-0040206-b002","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria: A comprehensive pro-poor health policy and strategy for the developing world.","volume":"3","year":"2006","journal-title":"PLoS Med"},{"key":"pmed-0040206-b003","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/AAC.47.5.1487-1495.2003","article-title":"Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed-0040206-b004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","article-title":"Drugs for the control of parasitic diseases: Current status and development in schistosomiasis.","volume":"19","year":"2003","journal-title":"Trends Parasitol"},{"key":"pmed-0040206-b005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0169-4758(93)90138-6","article-title":"Drug resistance in schistosomes.","volume":"9","year":"1993","journal-title":"Parasitol Today"},{"key":"pmed-0040206-b006","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4269\/ajtmh.1983.32.1040","article-title":"Survival of Schistosoma mansoni in the human host: Estimates from a community-based prospective study in Puerto Rico.","volume":"32","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"pmed-0040206-b007","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione.","volume":"52","year":"1983","journal-title":"Ann Rev Biochem"},{"key":"pmed-0040206-b008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease.","volume":"57","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"pmed-0040206-b009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/med.10051","article-title":"The thioredoxin system\u2014From science to clinic.","volume":"24","year":"2004","journal-title":"Med Res Rev"},{"key":"pmed-0040206-b010","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/anie.200300639","article-title":"Dithiol proteins as guardians of the intracellular redox milieu in parasites: Old and new drug targets in trypanosomes and malaria-causing plasmodia.","volume":"44","year":"2005","journal-title":"Angew Chem Int Ed Engl"},{"key":"pmed-0040206-b011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00031-2","article-title":"The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase.","volume":"121","year":"2002","journal-title":"Mol Biochem Parasitol"},{"key":"pmed-0040206-b012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbagen.2005.05.010","article-title":"Selenocysteine in proteins\u2014Properties and biotechnological use.","volume":"1726","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"pmed-0040206-b013","doi-asserted-by":"crossref","unstructured":"LewisF 1998 Schistosomiasis. In: ColiganJEKruisbeekAMMarguliesDHShevachEMStroberW Current protocols in immunology New York John Wiley & Sons pp. Suppl. 28: 19.1.1 19.1.28","DOI":"10.1002\/0471142735.im1901s28"},{"key":"pmed-0040206-b014","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/jmbi.1999.3085","article-title":"High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.","volume":"292","year":"1999","journal-title":"J Mol Biol"},{"key":"pmed-0040206-b015","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1128\/AEM.70.9.5159-5167.2004","article-title":"Assessment of production conditions for efficient use of Escherichia coli in high-yield heterologous recombinant selenoprotein synthesis.","volume":"70","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"pmed-0040206-b016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0076-6879(95)52023-6","article-title":"Thioredoxin and thioredoxin reductase.","volume":"252","year":"1995","journal-title":"Meth Enzymol"},{"key":"pmed-0040206-b017","unstructured":"Arn\u00e9rESJHolmgrenA 2000 Measurement of thioredoxin and thioredoxin reductase. In MainesMCostaLReedDSassaS Current protocols in toxicology New York John Wiley & Sons 7.4.1 7.4.14"},{"key":"pmed-0040206-b018","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0020-7519(02)00108-X","article-title":"Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin.","volume":"32","year":"2002","journal-title":"Int J Parasitol"},{"key":"pmed-0040206-b019","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","article-title":"Glutathione reductase.","volume":"113","year":"1985","journal-title":"Meth Enzymol"},{"key":"pmed-0040206-b020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0076-6879(95)52031-7","article-title":"Glutaredoxin.","volume":"252","year":"1995","journal-title":"Meth Enzymol"},{"key":"pmed-0040206-b021","unstructured":"SegelIH 1993 Enzyme kinetics New York John Wiley & Sons 957"},{"key":"pmed-0040206-b022","doi-asserted-by":"crossref","unstructured":"WendelA 1980 Glutathione peroxidase. In: JacobyWB Enzymatic basis of detoxification. Volume 1 New York Academic Press 333 353","DOI":"10.1016\/B978-0-12-380001-5.50022-0"},{"key":"pmed-0040206-b023","doi-asserted-by":"crossref","unstructured":"BergmeyerHUBerntE 1974 Lactate dehydrogenase. In: BergmeyerHU Methods of enzymatic analysis. Volume 2 New York Academic Press 574 548","DOI":"10.1016\/B978-0-12-091302-2.50009-8"},{"key":"pmed-0040206-b024","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0003-2697(80)90139-6","article-title":"Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.","volume":"106","year":"1980","journal-title":"Anal Biochem"},{"key":"pmed-0040206-b025","first-page":"107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening.","volume":"82","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"pmed-0040206-b026","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1073\/pnas.051454398","article-title":"Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems.","volume":"98","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pmed-0040206-b027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1432-1033.1974.tb03754.x","article-title":"Human glutathione reductase: Purification of the crystalline enzyme from erythrocytes.","volume":"48","year":"1974","journal-title":"Eur J Biochem"},{"key":"pmed-0040206-b028","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1432-1033.1976.tb10654.x","article-title":"Glutathione reductase from human erythrocytes. Catalytic properties and aggregation.","volume":"67","year":"1976","journal-title":"Eur J Biochem"},{"key":"pmed-0040206-b029","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.273.32.20096","article-title":"Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds.","volume":"273","year":"1998","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b030","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jinorgbio.2004.04.020","article-title":"Gold complexes inhibit mitochondrial thioredoxin reductase: Consequences on mitochondrial functions.","volume":"98","year":"2004","journal-title":"J Inorg Biochem"},{"key":"pmed-0040206-b031","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1021\/jm050256l","article-title":"Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible inhibitors of human thioredoxin reductase.","volume":"48","year":"2005","journal-title":"J Med Chem"},{"key":"pmed-0040206-b032","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.freeradbiomed.2005.04.025","article-title":"Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.","volume":"39","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"pmed-0040206-b033","doi-asserted-by":"crossref","first-page":"13319","DOI":"10.1021\/bi0353629","article-title":"Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.","volume":"42","year":"2003","journal-title":"Biochemistry"},{"key":"pmed-0040206-b034","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1021\/jm0504860","article-title":"Irreversible inhibition of trypanothione reductase by unsaturated Mannich bases: A divinylketone as key intermediate.","volume":"48","year":"2005","journal-title":"J Med Chem"},{"key":"pmed-0040206-b035","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1074\/jbc.M310292200","article-title":"Interactions of quinones with thioredoxin reductase: A challenge to the antioxidant role of the mammalian selenoprotein.","volume":"279","year":"2004","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b036","unstructured":"IrmlerABechtholdEDavioud-CharvetEHofmannVR\u00e9auR 2002 Disulfide reductases. In: ChapmanSPerhamRScruttonN Flavins and flavoproteins Berlin Agency for Scientific Publ 803 815"},{"key":"pmed-0040206-b037","first-page":"548","article-title":"2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: Synthesis and correlation between redox cycling activities and in vitro cytotoxicity.","volume":"15","year":"2001","journal-title":"J Med Chem"},{"key":"pmed-0040206-b038","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1021\/jm0497545","article-title":"5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials.","volume":"47","year":"2004","journal-title":"J Med Chem"},{"key":"pmed-0040206-b039","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1021\/jm010268g","article-title":"A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.","volume":"44","year":"2001","journal-title":"J Med Chem"},{"key":"pmed-0040206-b040","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/AAC.39.12.2671","article-title":"Antimalarial dyes revisited: Xanthenes, azines, oxazines and thiazines.","volume":"39","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"pmed-0040206-b041","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/jm950511+","article-title":"Inhibition of human glutathione reductase by 10-arylisoalloxazines: Crystallographic, kinetic, and electrochemical studies.","volume":"39","year":"1996","journal-title":"J Med Chem"},{"key":"pmed-0040206-b042","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.pa.25.040185.002413","article-title":"The chemotherapy of schistosomiasis.","volume":"25","year":"1985","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"pmed-0040206-b043","doi-asserted-by":"crossref","unstructured":"StandenOD 1963 Chemotherapy of helminthic infections. In: SchnitzerRJHawkingF Experimental chemotherapy. Volume 1 New York Academic Press 701 881","DOI":"10.1016\/B978-1-4832-3178-5.50026-5"},{"key":"pmed-0040206-b044","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0021-9258(18)50153-8","article-title":"Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.","volume":"237","year":"1962","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b045","doi-asserted-by":"crossref","first-page":"10784","DOI":"10.1021\/ja061155v","article-title":"A fluoro analogue of the menadione derivative 6-[2\u2032-(3\u2032-methyl)-1\u2032,4\u2032-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme.","volume":"128","year":"2006","journal-title":"J Am Chem Soc"},{"key":"pmed-0040206-b046","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0272-0590(88)90152-2","article-title":"Carcinogenicity study of auranofin, an orally administered gold compound, in mice.","volume":"11","year":"1988","journal-title":"Fundam Appl Toxicol"},{"key":"pmed-0040206-b047","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0169-4758(98)01261-7","article-title":"Do antioxidants play a role in schistosome host-parasite interactions?","volume":"14","year":"1998","journal-title":"Parasitol Today"},{"key":"pmed-0040206-b048","doi-asserted-by":"crossref","first-page":"14528","DOI":"10.1021\/bi051321w","article-title":"Reaction mechanism and regulation of mammalian thioredoxin\/glutathione reductase.","volume":"44","year":"2005","journal-title":"Biochemistry"},{"key":"pmed-0040206-b049","doi-asserted-by":"crossref","first-page":"22607","DOI":"10.1074\/jbc.272.36.22607","article-title":"Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase.","volume":"272","year":"1997","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b050","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1074\/jbc.M210456200","article-title":"The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress.","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b051","doi-asserted-by":"crossref","first-page":"26491","DOI":"10.1074\/jbc.M503638200","article-title":"Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation.","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b052","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-5793(95)01003-W","article-title":"Cloning and sequencing of a human thioredoxin reductase.","volume":"373","year":"1995","journal-title":"FEBS Lett"},{"key":"pmed-0040206-b053","first-page":"405","article-title":"The mitochondrial thioredoxin system.","volume":"261","year":"1999","journal-title":"Eur J Biochem"},{"key":"pmed-0040206-b054","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1074\/jbc.M312421200","article-title":"Alternative start sites in the Saccharomyces cerevisiae GLR1 gene are responsible for mitochondrial and cytosolic isoforms of glutathione reductase.","volume":"279","year":"2004","journal-title":"J Biol Chem"},{"key":"pmed-0040206-b055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pt.2004.05.002","article-title":"Linked thioredoxin-glutathione systems in platyhelminths.","volume":"20","year":"2004","journal-title":"Trends Parasitol"},{"key":"pmed-0040206-b056","first-page":"95","article-title":"Recent advances in schistosomiasis.","volume":"58","year":"1986","journal-title":"Q J Med"},{"key":"pmed-0040206-b057","first-page":"293","article-title":"The antischistosomal activity of oltipraz.","volume":"37","year":"1982","journal-title":"Res Comm Chem Path Pharmacol"},{"key":"pmed-0040206-b058","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0006-2952(90)90396-3","article-title":"Metabolism of oltipraz and glutathione reductase inhibition.","volume":"40","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"pmed-0040206-b059","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0006-2952(91)90532-A","article-title":"Toward an understanding of the schistosomicidal effect of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz).","volume":"41","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"pmed-0040206-b060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/tx0100340","article-title":"Kinetic constraints for the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution.","volume":"14","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"pmed-0040206-b061","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1021\/jo020588n","article-title":"Thiolytic chemistry of alternative precursors to the major metabolite of the cancer chemopreventive oltipraz.","volume":"67","year":"2002","journal-title":"J Org Chem"},{"key":"pmed-0040206-b062","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1021\/tx049687h","article-title":"Glutathione-mediated formation of oxygen free radicals by the major metabolite of oltipraz.","volume":"18","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"pmed-0040206-b063","first-page":"325","article-title":"The successful use of antimony in bilharziosis.","volume":"ii","year":"1918","journal-title":"Br Med J"},{"key":"pmed-0040206-b064","first-page":"459","article-title":"The actions of antimonials on glycolytic enzymes of Schistosoma mansoni.","volume":"9","year":"1954","journal-title":"Brit J Pharmacol"},{"key":"pmed-0040206-b065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0166-6851(96)02702-8","article-title":"Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni.","volume":"81","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"pmed-0040206-b066","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/rheumatology\/36.5.560","article-title":"Auranofin.","volume":"36","year":"1997","journal-title":"Br J Rheumatol"},{"key":"pmed-0040206-b067","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1432-1033.1996.0838w.x","article-title":"Selenium-containing phospholipids hydroperoxide glutathione peroxidase in Schistosoma mansoni.","volume":"238","year":"1996","journal-title":"Eur J Biochem"},{"key":"pmed-0040206-b068","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1568010033484142","article-title":"Effects of chrisotherapeutic gold compounds on prostaglandin E2 production.","volume":"2","year":"2003","journal-title":"Curr Drug Targets \u2013 Inflamm Allergy"},{"key":"pmed-0040206-b069","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/infdis\/151.6.1130","article-title":"Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.","volume":"151","year":"1985","journal-title":"J Infect Dis"},{"key":"pmed-0040206-b070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0014-4894(86)90184-0","article-title":"Schistosoma mansoni: Chemotherapy of infections of different ages.","volume":"61","year":"1986","journal-title":"Exp Parasitol"},{"key":"pmed-0040206-b071","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1383-5769(00)00028-3","article-title":"Preventive effect of artemether in experimental animals infected with Schistosoma mansoni.","volume":"49","year":"2000","journal-title":"Parasitol Int"},{"key":"pmed-0040206-b072","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.1074\/jbc.M210733200","article-title":"Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.","volume":"278","year":"2003","journal-title":"J Biol Chem"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.0040264","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:00:00Z","timestamp":1188259200000}}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.0040206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T21:18:01Z","timestamp":1707945481000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.0040206"}},"subtitle":[],"editor":[{"given":"Alex","family":"Loukas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,6,19]]},"references-count":72,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,6,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.0040206","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1088207.541223","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,19]]}}}